Global Pulmonary Surfactant Market Growth 2025-2031
The global Pulmonary Surfactant market size is predicted to grow from US$ 643 million in 2025 to US$ 845 million in 2031; it is expected to grow at a CAGR of 4.7% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Pulmonary surfactant is a mixture of lipids and proteins which is secreted into the alveolar space by epithelial type II cells. The main function of surfactant is to lower the surface tension at the air/liquid interface within the alveoli of the lung.
Increasing prevalence of respiratory infections are attributing to the highest share of North America market in the global pulmonary surfactant market
LP Information, Inc. (LPI) ' newest research report, the “Pulmonary Surfactant Industry Forecast” looks at past sales and reviews total world Pulmonary Surfactant sales in 2024, providing a comprehensive analysis by region and market sector of projected Pulmonary Surfactant sales for 2025 through 2031. With Pulmonary Surfactant sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pulmonary Surfactant industry.
This Insight Report provides a comprehensive analysis of the global Pulmonary Surfactant landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pulmonary Surfactant portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pulmonary Surfactant market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pulmonary Surfactant and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pulmonary Surfactant.
This report presents a comprehensive overview, market shares, and growth opportunities of Pulmonary Surfactant market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Pulmonary Surfactant market?
What factors are driving Pulmonary Surfactant market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pulmonary Surfactant market opportunities vary by end market size?
How does Pulmonary Surfactant break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Pulmonary surfactant is a mixture of lipids and proteins which is secreted into the alveolar space by epithelial type II cells. The main function of surfactant is to lower the surface tension at the air/liquid interface within the alveoli of the lung.
Increasing prevalence of respiratory infections are attributing to the highest share of North America market in the global pulmonary surfactant market
LP Information, Inc. (LPI) ' newest research report, the “Pulmonary Surfactant Industry Forecast” looks at past sales and reviews total world Pulmonary Surfactant sales in 2024, providing a comprehensive analysis by region and market sector of projected Pulmonary Surfactant sales for 2025 through 2031. With Pulmonary Surfactant sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pulmonary Surfactant industry.
This Insight Report provides a comprehensive analysis of the global Pulmonary Surfactant landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pulmonary Surfactant portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pulmonary Surfactant market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pulmonary Surfactant and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pulmonary Surfactant.
This report presents a comprehensive overview, market shares, and growth opportunities of Pulmonary Surfactant market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Synthetic Pulmonary Surfactants
- Animal Derived Surfactants
- Hospital
- laboratory
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Boehringer Ingelheim
- AbbVie
- Lyomark Pharma
- Tekzima (Noargen)
- ONY Biotech
- Abbott
- Aviva Systems Biology
- LSBio
- Biomatik
- Biorbyt
- Reddot Biotech
- XpressBio
- Creative Diagnostics
- Nanjing Norris Pharm Technology
- Windtree Therapeutics
What is the 10-year outlook for the global Pulmonary Surfactant market?
What factors are driving Pulmonary Surfactant market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pulmonary Surfactant market opportunities vary by end market size?
How does Pulmonary Surfactant break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pulmonary Surfactant Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pulmonary Surfactant by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pulmonary Surfactant by Country/Region, 2020, 2024 & 2031
2.2 Pulmonary Surfactant Segment by Type
2.2.1 Synthetic Pulmonary Surfactants
2.2.2 Animal Derived Surfactants
2.3 Pulmonary Surfactant Sales by Type
2.3.1 Global Pulmonary Surfactant Sales Market Share by Type (2020-2025)
2.3.2 Global Pulmonary Surfactant Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pulmonary Surfactant Sale Price by Type (2020-2025)
2.4 Pulmonary Surfactant Segment by Application
2.4.1 Hospital
2.4.2 laboratory
2.4.3 Others
2.5 Pulmonary Surfactant Sales by Application
2.5.1 Global Pulmonary Surfactant Sale Market Share by Application (2020-2025)
2.5.2 Global Pulmonary Surfactant Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pulmonary Surfactant Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Pulmonary Surfactant Breakdown Data by Company
3.1.1 Global Pulmonary Surfactant Annual Sales by Company (2020-2025)
3.1.2 Global Pulmonary Surfactant Sales Market Share by Company (2020-2025)
3.2 Global Pulmonary Surfactant Annual Revenue by Company (2020-2025)
3.2.1 Global Pulmonary Surfactant Revenue by Company (2020-2025)
3.2.2 Global Pulmonary Surfactant Revenue Market Share by Company (2020-2025)
3.3 Global Pulmonary Surfactant Sale Price by Company
3.4 Key Manufacturers Pulmonary Surfactant Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pulmonary Surfactant Product Location Distribution
3.4.2 Players Pulmonary Surfactant Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PULMONARY SURFACTANT BY GEOGRAPHIC REGION
4.1 World Historic Pulmonary Surfactant Market Size by Geographic Region (2020-2025)
4.1.1 Global Pulmonary Surfactant Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pulmonary Surfactant Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pulmonary Surfactant Market Size by Country/Region (2020-2025)
4.2.1 Global Pulmonary Surfactant Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pulmonary Surfactant Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pulmonary Surfactant Sales Growth
4.4 APAC Pulmonary Surfactant Sales Growth
4.5 Europe Pulmonary Surfactant Sales Growth
4.6 Middle East & Africa Pulmonary Surfactant Sales Growth
5 AMERICAS
5.1 Americas Pulmonary Surfactant Sales by Country
5.1.1 Americas Pulmonary Surfactant Sales by Country (2020-2025)
5.1.2 Americas Pulmonary Surfactant Revenue by Country (2020-2025)
5.2 Americas Pulmonary Surfactant Sales by Type (2020-2025)
5.3 Americas Pulmonary Surfactant Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pulmonary Surfactant Sales by Region
6.1.1 APAC Pulmonary Surfactant Sales by Region (2020-2025)
6.1.2 APAC Pulmonary Surfactant Revenue by Region (2020-2025)
6.2 APAC Pulmonary Surfactant Sales by Type (2020-2025)
6.3 APAC Pulmonary Surfactant Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pulmonary Surfactant by Country
7.1.1 Europe Pulmonary Surfactant Sales by Country (2020-2025)
7.1.2 Europe Pulmonary Surfactant Revenue by Country (2020-2025)
7.2 Europe Pulmonary Surfactant Sales by Type (2020-2025)
7.3 Europe Pulmonary Surfactant Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pulmonary Surfactant by Country
8.1.1 Middle East & Africa Pulmonary Surfactant Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pulmonary Surfactant Revenue by Country (2020-2025)
8.2 Middle East & Africa Pulmonary Surfactant Sales by Type (2020-2025)
8.3 Middle East & Africa Pulmonary Surfactant Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pulmonary Surfactant
10.3 Manufacturing Process Analysis of Pulmonary Surfactant
10.4 Industry Chain Structure of Pulmonary Surfactant
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pulmonary Surfactant Distributors
11.3 Pulmonary Surfactant Customer
12 WORLD FORECAST REVIEW FOR PULMONARY SURFACTANT BY GEOGRAPHIC REGION
12.1 Global Pulmonary Surfactant Market Size Forecast by Region
12.1.1 Global Pulmonary Surfactant Forecast by Region (2026-2031)
12.1.2 Global Pulmonary Surfactant Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pulmonary Surfactant Forecast by Type (2026-2031)
12.7 Global Pulmonary Surfactant Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Pulmonary Surfactant Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 AbbVie
13.2.1 AbbVie Company Information
13.2.2 AbbVie Pulmonary Surfactant Product Portfolios and Specifications
13.2.3 AbbVie Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 AbbVie Main Business Overview
13.2.5 AbbVie Latest Developments
13.3 Lyomark Pharma
13.3.1 Lyomark Pharma Company Information
13.3.2 Lyomark Pharma Pulmonary Surfactant Product Portfolios and Specifications
13.3.3 Lyomark Pharma Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Lyomark Pharma Main Business Overview
13.3.5 Lyomark Pharma Latest Developments
13.4 Tekzima (Noargen)
13.4.1 Tekzima (Noargen) Company Information
13.4.2 Tekzima (Noargen) Pulmonary Surfactant Product Portfolios and Specifications
13.4.3 Tekzima (Noargen) Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Tekzima (Noargen) Main Business Overview
13.4.5 Tekzima (Noargen) Latest Developments
13.5 ONY Biotech
13.5.1 ONY Biotech Company Information
13.5.2 ONY Biotech Pulmonary Surfactant Product Portfolios and Specifications
13.5.3 ONY Biotech Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 ONY Biotech Main Business Overview
13.5.5 ONY Biotech Latest Developments
13.6 Abbott
13.6.1 Abbott Company Information
13.6.2 Abbott Pulmonary Surfactant Product Portfolios and Specifications
13.6.3 Abbott Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Abbott Main Business Overview
13.6.5 Abbott Latest Developments
13.7 Aviva Systems Biology
13.7.1 Aviva Systems Biology Company Information
13.7.2 Aviva Systems Biology Pulmonary Surfactant Product Portfolios and Specifications
13.7.3 Aviva Systems Biology Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Aviva Systems Biology Main Business Overview
13.7.5 Aviva Systems Biology Latest Developments
13.8 LSBio
13.8.1 LSBio Company Information
13.8.2 LSBio Pulmonary Surfactant Product Portfolios and Specifications
13.8.3 LSBio Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 LSBio Main Business Overview
13.8.5 LSBio Latest Developments
13.9 Biomatik
13.9.1 Biomatik Company Information
13.9.2 Biomatik Pulmonary Surfactant Product Portfolios and Specifications
13.9.3 Biomatik Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Biomatik Main Business Overview
13.9.5 Biomatik Latest Developments
13.10 Biorbyt
13.10.1 Biorbyt Company Information
13.10.2 Biorbyt Pulmonary Surfactant Product Portfolios and Specifications
13.10.3 Biorbyt Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Biorbyt Main Business Overview
13.10.5 Biorbyt Latest Developments
13.11 Reddot Biotech
13.11.1 Reddot Biotech Company Information
13.11.2 Reddot Biotech Pulmonary Surfactant Product Portfolios and Specifications
13.11.3 Reddot Biotech Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Reddot Biotech Main Business Overview
13.11.5 Reddot Biotech Latest Developments
13.12 XpressBio
13.12.1 XpressBio Company Information
13.12.2 XpressBio Pulmonary Surfactant Product Portfolios and Specifications
13.12.3 XpressBio Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 XpressBio Main Business Overview
13.12.5 XpressBio Latest Developments
13.13 Creative Diagnostics
13.13.1 Creative Diagnostics Company Information
13.13.2 Creative Diagnostics Pulmonary Surfactant Product Portfolios and Specifications
13.13.3 Creative Diagnostics Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Creative Diagnostics Main Business Overview
13.13.5 Creative Diagnostics Latest Developments
13.14 Nanjing Norris Pharm Technology
13.14.1 Nanjing Norris Pharm Technology Company Information
13.14.2 Nanjing Norris Pharm Technology Pulmonary Surfactant Product Portfolios and Specifications
13.14.3 Nanjing Norris Pharm Technology Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Nanjing Norris Pharm Technology Main Business Overview
13.14.5 Nanjing Norris Pharm Technology Latest Developments
13.15 Windtree Therapeutics
13.15.1 Windtree Therapeutics Company Information
13.15.2 Windtree Therapeutics Pulmonary Surfactant Product Portfolios and Specifications
13.15.3 Windtree Therapeutics Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Windtree Therapeutics Main Business Overview
13.15.5 Windtree Therapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pulmonary Surfactant Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pulmonary Surfactant by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pulmonary Surfactant by Country/Region, 2020, 2024 & 2031
2.2 Pulmonary Surfactant Segment by Type
2.2.1 Synthetic Pulmonary Surfactants
2.2.2 Animal Derived Surfactants
2.3 Pulmonary Surfactant Sales by Type
2.3.1 Global Pulmonary Surfactant Sales Market Share by Type (2020-2025)
2.3.2 Global Pulmonary Surfactant Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pulmonary Surfactant Sale Price by Type (2020-2025)
2.4 Pulmonary Surfactant Segment by Application
2.4.1 Hospital
2.4.2 laboratory
2.4.3 Others
2.5 Pulmonary Surfactant Sales by Application
2.5.1 Global Pulmonary Surfactant Sale Market Share by Application (2020-2025)
2.5.2 Global Pulmonary Surfactant Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pulmonary Surfactant Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Pulmonary Surfactant Breakdown Data by Company
3.1.1 Global Pulmonary Surfactant Annual Sales by Company (2020-2025)
3.1.2 Global Pulmonary Surfactant Sales Market Share by Company (2020-2025)
3.2 Global Pulmonary Surfactant Annual Revenue by Company (2020-2025)
3.2.1 Global Pulmonary Surfactant Revenue by Company (2020-2025)
3.2.2 Global Pulmonary Surfactant Revenue Market Share by Company (2020-2025)
3.3 Global Pulmonary Surfactant Sale Price by Company
3.4 Key Manufacturers Pulmonary Surfactant Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pulmonary Surfactant Product Location Distribution
3.4.2 Players Pulmonary Surfactant Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PULMONARY SURFACTANT BY GEOGRAPHIC REGION
4.1 World Historic Pulmonary Surfactant Market Size by Geographic Region (2020-2025)
4.1.1 Global Pulmonary Surfactant Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pulmonary Surfactant Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pulmonary Surfactant Market Size by Country/Region (2020-2025)
4.2.1 Global Pulmonary Surfactant Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pulmonary Surfactant Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pulmonary Surfactant Sales Growth
4.4 APAC Pulmonary Surfactant Sales Growth
4.5 Europe Pulmonary Surfactant Sales Growth
4.6 Middle East & Africa Pulmonary Surfactant Sales Growth
5 AMERICAS
5.1 Americas Pulmonary Surfactant Sales by Country
5.1.1 Americas Pulmonary Surfactant Sales by Country (2020-2025)
5.1.2 Americas Pulmonary Surfactant Revenue by Country (2020-2025)
5.2 Americas Pulmonary Surfactant Sales by Type (2020-2025)
5.3 Americas Pulmonary Surfactant Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pulmonary Surfactant Sales by Region
6.1.1 APAC Pulmonary Surfactant Sales by Region (2020-2025)
6.1.2 APAC Pulmonary Surfactant Revenue by Region (2020-2025)
6.2 APAC Pulmonary Surfactant Sales by Type (2020-2025)
6.3 APAC Pulmonary Surfactant Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pulmonary Surfactant by Country
7.1.1 Europe Pulmonary Surfactant Sales by Country (2020-2025)
7.1.2 Europe Pulmonary Surfactant Revenue by Country (2020-2025)
7.2 Europe Pulmonary Surfactant Sales by Type (2020-2025)
7.3 Europe Pulmonary Surfactant Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pulmonary Surfactant by Country
8.1.1 Middle East & Africa Pulmonary Surfactant Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pulmonary Surfactant Revenue by Country (2020-2025)
8.2 Middle East & Africa Pulmonary Surfactant Sales by Type (2020-2025)
8.3 Middle East & Africa Pulmonary Surfactant Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pulmonary Surfactant
10.3 Manufacturing Process Analysis of Pulmonary Surfactant
10.4 Industry Chain Structure of Pulmonary Surfactant
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pulmonary Surfactant Distributors
11.3 Pulmonary Surfactant Customer
12 WORLD FORECAST REVIEW FOR PULMONARY SURFACTANT BY GEOGRAPHIC REGION
12.1 Global Pulmonary Surfactant Market Size Forecast by Region
12.1.1 Global Pulmonary Surfactant Forecast by Region (2026-2031)
12.1.2 Global Pulmonary Surfactant Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pulmonary Surfactant Forecast by Type (2026-2031)
12.7 Global Pulmonary Surfactant Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Pulmonary Surfactant Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 AbbVie
13.2.1 AbbVie Company Information
13.2.2 AbbVie Pulmonary Surfactant Product Portfolios and Specifications
13.2.3 AbbVie Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 AbbVie Main Business Overview
13.2.5 AbbVie Latest Developments
13.3 Lyomark Pharma
13.3.1 Lyomark Pharma Company Information
13.3.2 Lyomark Pharma Pulmonary Surfactant Product Portfolios and Specifications
13.3.3 Lyomark Pharma Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Lyomark Pharma Main Business Overview
13.3.5 Lyomark Pharma Latest Developments
13.4 Tekzima (Noargen)
13.4.1 Tekzima (Noargen) Company Information
13.4.2 Tekzima (Noargen) Pulmonary Surfactant Product Portfolios and Specifications
13.4.3 Tekzima (Noargen) Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Tekzima (Noargen) Main Business Overview
13.4.5 Tekzima (Noargen) Latest Developments
13.5 ONY Biotech
13.5.1 ONY Biotech Company Information
13.5.2 ONY Biotech Pulmonary Surfactant Product Portfolios and Specifications
13.5.3 ONY Biotech Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 ONY Biotech Main Business Overview
13.5.5 ONY Biotech Latest Developments
13.6 Abbott
13.6.1 Abbott Company Information
13.6.2 Abbott Pulmonary Surfactant Product Portfolios and Specifications
13.6.3 Abbott Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Abbott Main Business Overview
13.6.5 Abbott Latest Developments
13.7 Aviva Systems Biology
13.7.1 Aviva Systems Biology Company Information
13.7.2 Aviva Systems Biology Pulmonary Surfactant Product Portfolios and Specifications
13.7.3 Aviva Systems Biology Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Aviva Systems Biology Main Business Overview
13.7.5 Aviva Systems Biology Latest Developments
13.8 LSBio
13.8.1 LSBio Company Information
13.8.2 LSBio Pulmonary Surfactant Product Portfolios and Specifications
13.8.3 LSBio Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 LSBio Main Business Overview
13.8.5 LSBio Latest Developments
13.9 Biomatik
13.9.1 Biomatik Company Information
13.9.2 Biomatik Pulmonary Surfactant Product Portfolios and Specifications
13.9.3 Biomatik Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Biomatik Main Business Overview
13.9.5 Biomatik Latest Developments
13.10 Biorbyt
13.10.1 Biorbyt Company Information
13.10.2 Biorbyt Pulmonary Surfactant Product Portfolios and Specifications
13.10.3 Biorbyt Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Biorbyt Main Business Overview
13.10.5 Biorbyt Latest Developments
13.11 Reddot Biotech
13.11.1 Reddot Biotech Company Information
13.11.2 Reddot Biotech Pulmonary Surfactant Product Portfolios and Specifications
13.11.3 Reddot Biotech Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Reddot Biotech Main Business Overview
13.11.5 Reddot Biotech Latest Developments
13.12 XpressBio
13.12.1 XpressBio Company Information
13.12.2 XpressBio Pulmonary Surfactant Product Portfolios and Specifications
13.12.3 XpressBio Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 XpressBio Main Business Overview
13.12.5 XpressBio Latest Developments
13.13 Creative Diagnostics
13.13.1 Creative Diagnostics Company Information
13.13.2 Creative Diagnostics Pulmonary Surfactant Product Portfolios and Specifications
13.13.3 Creative Diagnostics Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Creative Diagnostics Main Business Overview
13.13.5 Creative Diagnostics Latest Developments
13.14 Nanjing Norris Pharm Technology
13.14.1 Nanjing Norris Pharm Technology Company Information
13.14.2 Nanjing Norris Pharm Technology Pulmonary Surfactant Product Portfolios and Specifications
13.14.3 Nanjing Norris Pharm Technology Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Nanjing Norris Pharm Technology Main Business Overview
13.14.5 Nanjing Norris Pharm Technology Latest Developments
13.15 Windtree Therapeutics
13.15.1 Windtree Therapeutics Company Information
13.15.2 Windtree Therapeutics Pulmonary Surfactant Product Portfolios and Specifications
13.15.3 Windtree Therapeutics Pulmonary Surfactant Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Windtree Therapeutics Main Business Overview
13.15.5 Windtree Therapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pulmonary Surfactant Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Pulmonary Surfactant Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Synthetic Pulmonary Surfactants
Table 4. Major Players of Animal Derived Surfactants
Table 5. Global Pulmonary Surfactant Sales by Type (2020-2025) & (K Units)
Table 6. Global Pulmonary Surfactant Sales Market Share by Type (2020-2025)
Table 7. Global Pulmonary Surfactant Revenue by Type (2020-2025) & ($ million)
Table 8. Global Pulmonary Surfactant Revenue Market Share by Type (2020-2025)
Table 9. Global Pulmonary Surfactant Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Pulmonary Surfactant Sale by Application (2020-2025) & (K Units)
Table 11. Global Pulmonary Surfactant Sale Market Share by Application (2020-2025)
Table 12. Global Pulmonary Surfactant Revenue by Application (2020-2025) & ($ million)
Table 13. Global Pulmonary Surfactant Revenue Market Share by Application (2020-2025)
Table 14. Global Pulmonary Surfactant Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Pulmonary Surfactant Sales by Company (2020-2025) & (K Units)
Table 16. Global Pulmonary Surfactant Sales Market Share by Company (2020-2025)
Table 17. Global Pulmonary Surfactant Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Pulmonary Surfactant Revenue Market Share by Company (2020-2025)
Table 19. Global Pulmonary Surfactant Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Pulmonary Surfactant Producing Area Distribution and Sales Area
Table 21. Players Pulmonary Surfactant Products Offered
Table 22. Pulmonary Surfactant Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Pulmonary Surfactant Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Pulmonary Surfactant Sales Market Share Geographic Region (2020-2025)
Table 27. Global Pulmonary Surfactant Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Pulmonary Surfactant Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Pulmonary Surfactant Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Pulmonary Surfactant Sales Market Share by Country/Region (2020-2025)
Table 31. Global Pulmonary Surfactant Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Pulmonary Surfactant Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Pulmonary Surfactant Sales by Country (2020-2025) & (K Units)
Table 34. Americas Pulmonary Surfactant Sales Market Share by Country (2020-2025)
Table 35. Americas Pulmonary Surfactant Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Pulmonary Surfactant Sales by Type (2020-2025) & (K Units)
Table 37. Americas Pulmonary Surfactant Sales by Application (2020-2025) & (K Units)
Table 38. APAC Pulmonary Surfactant Sales by Region (2020-2025) & (K Units)
Table 39. APAC Pulmonary Surfactant Sales Market Share by Region (2020-2025)
Table 40. APAC Pulmonary Surfactant Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Pulmonary Surfactant Sales by Type (2020-2025) & (K Units)
Table 42. APAC Pulmonary Surfactant Sales by Application (2020-2025) & (K Units)
Table 43. Europe Pulmonary Surfactant Sales by Country (2020-2025) & (K Units)
Table 44. Europe Pulmonary Surfactant Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Pulmonary Surfactant Sales by Type (2020-2025) & (K Units)
Table 46. Europe Pulmonary Surfactant Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Pulmonary Surfactant Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Pulmonary Surfactant Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Pulmonary Surfactant Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Pulmonary Surfactant Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Pulmonary Surfactant
Table 52. Key Market Challenges & Risks of Pulmonary Surfactant
Table 53. Key Industry Trends of Pulmonary Surfactant
Table 54. Pulmonary Surfactant Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Pulmonary Surfactant Distributors List
Table 57. Pulmonary Surfactant Customer List
Table 58. Global Pulmonary Surfactant Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Pulmonary Surfactant Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Pulmonary Surfactant Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Pulmonary Surfactant Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Pulmonary Surfactant Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Pulmonary Surfactant Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Pulmonary Surfactant Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Pulmonary Surfactant Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Pulmonary Surfactant Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Pulmonary Surfactant Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Pulmonary Surfactant Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Pulmonary Surfactant Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Pulmonary Surfactant Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Pulmonary Surfactant Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Boehringer Ingelheim Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 73. Boehringer Ingelheim Pulmonary Surfactant Product Portfolios and Specifications
Table 74. Boehringer Ingelheim Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Boehringer Ingelheim Main Business
Table 76. Boehringer Ingelheim Latest Developments
Table 77. AbbVie Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 78. AbbVie Pulmonary Surfactant Product Portfolios and Specifications
Table 79. AbbVie Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. AbbVie Main Business
Table 81. AbbVie Latest Developments
Table 82. Lyomark Pharma Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 83. Lyomark Pharma Pulmonary Surfactant Product Portfolios and Specifications
Table 84. Lyomark Pharma Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Lyomark Pharma Main Business
Table 86. Lyomark Pharma Latest Developments
Table 87. Tekzima (Noargen) Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 88. Tekzima (Noargen) Pulmonary Surfactant Product Portfolios and Specifications
Table 89. Tekzima (Noargen) Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Tekzima (Noargen) Main Business
Table 91. Tekzima (Noargen) Latest Developments
Table 92. ONY Biotech Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 93. ONY Biotech Pulmonary Surfactant Product Portfolios and Specifications
Table 94. ONY Biotech Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. ONY Biotech Main Business
Table 96. ONY Biotech Latest Developments
Table 97. Abbott Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 98. Abbott Pulmonary Surfactant Product Portfolios and Specifications
Table 99. Abbott Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Abbott Main Business
Table 101. Abbott Latest Developments
Table 102. Aviva Systems Biology Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 103. Aviva Systems Biology Pulmonary Surfactant Product Portfolios and Specifications
Table 104. Aviva Systems Biology Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Aviva Systems Biology Main Business
Table 106. Aviva Systems Biology Latest Developments
Table 107. LSBio Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 108. LSBio Pulmonary Surfactant Product Portfolios and Specifications
Table 109. LSBio Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. LSBio Main Business
Table 111. LSBio Latest Developments
Table 112. Biomatik Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 113. Biomatik Pulmonary Surfactant Product Portfolios and Specifications
Table 114. Biomatik Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Biomatik Main Business
Table 116. Biomatik Latest Developments
Table 117. Biorbyt Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 118. Biorbyt Pulmonary Surfactant Product Portfolios and Specifications
Table 119. Biorbyt Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Biorbyt Main Business
Table 121. Biorbyt Latest Developments
Table 122. Reddot Biotech Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 123. Reddot Biotech Pulmonary Surfactant Product Portfolios and Specifications
Table 124. Reddot Biotech Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Reddot Biotech Main Business
Table 126. Reddot Biotech Latest Developments
Table 127. XpressBio Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 128. XpressBio Pulmonary Surfactant Product Portfolios and Specifications
Table 129. XpressBio Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. XpressBio Main Business
Table 131. XpressBio Latest Developments
Table 132. Creative Diagnostics Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 133. Creative Diagnostics Pulmonary Surfactant Product Portfolios and Specifications
Table 134. Creative Diagnostics Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 135. Creative Diagnostics Main Business
Table 136. Creative Diagnostics Latest Developments
Table 137. Nanjing Norris Pharm Technology Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 138. Nanjing Norris Pharm Technology Pulmonary Surfactant Product Portfolios and Specifications
Table 139. Nanjing Norris Pharm Technology Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 140. Nanjing Norris Pharm Technology Main Business
Table 141. Nanjing Norris Pharm Technology Latest Developments
Table 142. Windtree Therapeutics Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 143. Windtree Therapeutics Pulmonary Surfactant Product Portfolios and Specifications
Table 144. Windtree Therapeutics Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 145. Windtree Therapeutics Main Business
Table 146. Windtree Therapeutics Latest Developments
Table 1. Pulmonary Surfactant Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Pulmonary Surfactant Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Synthetic Pulmonary Surfactants
Table 4. Major Players of Animal Derived Surfactants
Table 5. Global Pulmonary Surfactant Sales by Type (2020-2025) & (K Units)
Table 6. Global Pulmonary Surfactant Sales Market Share by Type (2020-2025)
Table 7. Global Pulmonary Surfactant Revenue by Type (2020-2025) & ($ million)
Table 8. Global Pulmonary Surfactant Revenue Market Share by Type (2020-2025)
Table 9. Global Pulmonary Surfactant Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Pulmonary Surfactant Sale by Application (2020-2025) & (K Units)
Table 11. Global Pulmonary Surfactant Sale Market Share by Application (2020-2025)
Table 12. Global Pulmonary Surfactant Revenue by Application (2020-2025) & ($ million)
Table 13. Global Pulmonary Surfactant Revenue Market Share by Application (2020-2025)
Table 14. Global Pulmonary Surfactant Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Pulmonary Surfactant Sales by Company (2020-2025) & (K Units)
Table 16. Global Pulmonary Surfactant Sales Market Share by Company (2020-2025)
Table 17. Global Pulmonary Surfactant Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Pulmonary Surfactant Revenue Market Share by Company (2020-2025)
Table 19. Global Pulmonary Surfactant Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Pulmonary Surfactant Producing Area Distribution and Sales Area
Table 21. Players Pulmonary Surfactant Products Offered
Table 22. Pulmonary Surfactant Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Pulmonary Surfactant Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Pulmonary Surfactant Sales Market Share Geographic Region (2020-2025)
Table 27. Global Pulmonary Surfactant Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Pulmonary Surfactant Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Pulmonary Surfactant Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Pulmonary Surfactant Sales Market Share by Country/Region (2020-2025)
Table 31. Global Pulmonary Surfactant Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Pulmonary Surfactant Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Pulmonary Surfactant Sales by Country (2020-2025) & (K Units)
Table 34. Americas Pulmonary Surfactant Sales Market Share by Country (2020-2025)
Table 35. Americas Pulmonary Surfactant Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Pulmonary Surfactant Sales by Type (2020-2025) & (K Units)
Table 37. Americas Pulmonary Surfactant Sales by Application (2020-2025) & (K Units)
Table 38. APAC Pulmonary Surfactant Sales by Region (2020-2025) & (K Units)
Table 39. APAC Pulmonary Surfactant Sales Market Share by Region (2020-2025)
Table 40. APAC Pulmonary Surfactant Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Pulmonary Surfactant Sales by Type (2020-2025) & (K Units)
Table 42. APAC Pulmonary Surfactant Sales by Application (2020-2025) & (K Units)
Table 43. Europe Pulmonary Surfactant Sales by Country (2020-2025) & (K Units)
Table 44. Europe Pulmonary Surfactant Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Pulmonary Surfactant Sales by Type (2020-2025) & (K Units)
Table 46. Europe Pulmonary Surfactant Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Pulmonary Surfactant Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Pulmonary Surfactant Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Pulmonary Surfactant Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Pulmonary Surfactant Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Pulmonary Surfactant
Table 52. Key Market Challenges & Risks of Pulmonary Surfactant
Table 53. Key Industry Trends of Pulmonary Surfactant
Table 54. Pulmonary Surfactant Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Pulmonary Surfactant Distributors List
Table 57. Pulmonary Surfactant Customer List
Table 58. Global Pulmonary Surfactant Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Pulmonary Surfactant Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Pulmonary Surfactant Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Pulmonary Surfactant Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Pulmonary Surfactant Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Pulmonary Surfactant Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Pulmonary Surfactant Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Pulmonary Surfactant Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Pulmonary Surfactant Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Pulmonary Surfactant Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Pulmonary Surfactant Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Pulmonary Surfactant Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Pulmonary Surfactant Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Pulmonary Surfactant Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Boehringer Ingelheim Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 73. Boehringer Ingelheim Pulmonary Surfactant Product Portfolios and Specifications
Table 74. Boehringer Ingelheim Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Boehringer Ingelheim Main Business
Table 76. Boehringer Ingelheim Latest Developments
Table 77. AbbVie Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 78. AbbVie Pulmonary Surfactant Product Portfolios and Specifications
Table 79. AbbVie Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. AbbVie Main Business
Table 81. AbbVie Latest Developments
Table 82. Lyomark Pharma Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 83. Lyomark Pharma Pulmonary Surfactant Product Portfolios and Specifications
Table 84. Lyomark Pharma Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Lyomark Pharma Main Business
Table 86. Lyomark Pharma Latest Developments
Table 87. Tekzima (Noargen) Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 88. Tekzima (Noargen) Pulmonary Surfactant Product Portfolios and Specifications
Table 89. Tekzima (Noargen) Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Tekzima (Noargen) Main Business
Table 91. Tekzima (Noargen) Latest Developments
Table 92. ONY Biotech Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 93. ONY Biotech Pulmonary Surfactant Product Portfolios and Specifications
Table 94. ONY Biotech Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. ONY Biotech Main Business
Table 96. ONY Biotech Latest Developments
Table 97. Abbott Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 98. Abbott Pulmonary Surfactant Product Portfolios and Specifications
Table 99. Abbott Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Abbott Main Business
Table 101. Abbott Latest Developments
Table 102. Aviva Systems Biology Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 103. Aviva Systems Biology Pulmonary Surfactant Product Portfolios and Specifications
Table 104. Aviva Systems Biology Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Aviva Systems Biology Main Business
Table 106. Aviva Systems Biology Latest Developments
Table 107. LSBio Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 108. LSBio Pulmonary Surfactant Product Portfolios and Specifications
Table 109. LSBio Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. LSBio Main Business
Table 111. LSBio Latest Developments
Table 112. Biomatik Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 113. Biomatik Pulmonary Surfactant Product Portfolios and Specifications
Table 114. Biomatik Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Biomatik Main Business
Table 116. Biomatik Latest Developments
Table 117. Biorbyt Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 118. Biorbyt Pulmonary Surfactant Product Portfolios and Specifications
Table 119. Biorbyt Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Biorbyt Main Business
Table 121. Biorbyt Latest Developments
Table 122. Reddot Biotech Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 123. Reddot Biotech Pulmonary Surfactant Product Portfolios and Specifications
Table 124. Reddot Biotech Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Reddot Biotech Main Business
Table 126. Reddot Biotech Latest Developments
Table 127. XpressBio Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 128. XpressBio Pulmonary Surfactant Product Portfolios and Specifications
Table 129. XpressBio Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. XpressBio Main Business
Table 131. XpressBio Latest Developments
Table 132. Creative Diagnostics Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 133. Creative Diagnostics Pulmonary Surfactant Product Portfolios and Specifications
Table 134. Creative Diagnostics Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 135. Creative Diagnostics Main Business
Table 136. Creative Diagnostics Latest Developments
Table 137. Nanjing Norris Pharm Technology Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 138. Nanjing Norris Pharm Technology Pulmonary Surfactant Product Portfolios and Specifications
Table 139. Nanjing Norris Pharm Technology Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 140. Nanjing Norris Pharm Technology Main Business
Table 141. Nanjing Norris Pharm Technology Latest Developments
Table 142. Windtree Therapeutics Basic Information, Pulmonary Surfactant Manufacturing Base, Sales Area and Its Competitors
Table 143. Windtree Therapeutics Pulmonary Surfactant Product Portfolios and Specifications
Table 144. Windtree Therapeutics Pulmonary Surfactant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 145. Windtree Therapeutics Main Business
Table 146. Windtree Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pulmonary Surfactant
Figure 2. Pulmonary Surfactant Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pulmonary Surfactant Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Pulmonary Surfactant Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Pulmonary Surfactant Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Pulmonary Surfactant Sales Market Share by Country/Region (2024)
Figure 10. Pulmonary Surfactant Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Synthetic Pulmonary Surfactants
Figure 12. Product Picture of Animal Derived Surfactants
Figure 13. Global Pulmonary Surfactant Sales Market Share by Type in 2025
Figure 14. Global Pulmonary Surfactant Revenue Market Share by Type (2020-2025)
Figure 15. Pulmonary Surfactant Consumed in Hospital
Figure 16. Global Pulmonary Surfactant Market: Hospital (2020-2025) & (K Units)
Figure 17. Pulmonary Surfactant Consumed in laboratory
Figure 18. Global Pulmonary Surfactant Market: laboratory (2020-2025) & (K Units)
Figure 19. Pulmonary Surfactant Consumed in Others
Figure 20. Global Pulmonary Surfactant Market: Others (2020-2025) & (K Units)
Figure 21. Global Pulmonary Surfactant Sale Market Share by Application (2024)
Figure 22. Global Pulmonary Surfactant Revenue Market Share by Application in 2025
Figure 23. Pulmonary Surfactant Sales by Company in 2025 (K Units)
Figure 24. Global Pulmonary Surfactant Sales Market Share by Company in 2025
Figure 25. Pulmonary Surfactant Revenue by Company in 2025 ($ millions)
Figure 26. Global Pulmonary Surfactant Revenue Market Share by Company in 2025
Figure 27. Global Pulmonary Surfactant Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Pulmonary Surfactant Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Pulmonary Surfactant Sales 2020-2025 (K Units)
Figure 30. Americas Pulmonary Surfactant Revenue 2020-2025 ($ millions)
Figure 31. APAC Pulmonary Surfactant Sales 2020-2025 (K Units)
Figure 32. APAC Pulmonary Surfactant Revenue 2020-2025 ($ millions)
Figure 33. Europe Pulmonary Surfactant Sales 2020-2025 (K Units)
Figure 34. Europe Pulmonary Surfactant Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Pulmonary Surfactant Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Pulmonary Surfactant Revenue 2020-2025 ($ millions)
Figure 37. Americas Pulmonary Surfactant Sales Market Share by Country in 2025
Figure 38. Americas Pulmonary Surfactant Revenue Market Share by Country (2020-2025)
Figure 39. Americas Pulmonary Surfactant Sales Market Share by Type (2020-2025)
Figure 40. Americas Pulmonary Surfactant Sales Market Share by Application (2020-2025)
Figure 41. United States Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Pulmonary Surfactant Sales Market Share by Region in 2025
Figure 46. APAC Pulmonary Surfactant Revenue Market Share by Region (2020-2025)
Figure 47. APAC Pulmonary Surfactant Sales Market Share by Type (2020-2025)
Figure 48. APAC Pulmonary Surfactant Sales Market Share by Application (2020-2025)
Figure 49. China Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 53. India Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Pulmonary Surfactant Sales Market Share by Country in 2025
Figure 57. Europe Pulmonary Surfactant Revenue Market Share by Country (2020-2025)
Figure 58. Europe Pulmonary Surfactant Sales Market Share by Type (2020-2025)
Figure 59. Europe Pulmonary Surfactant Sales Market Share by Application (2020-2025)
Figure 60. Germany Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 61. France Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Pulmonary Surfactant Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Pulmonary Surfactant Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Pulmonary Surfactant Sales Market Share by Application (2020-2025)
Figure 68. Egypt Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Pulmonary Surfactant in 2025
Figure 74. Manufacturing Process Analysis of Pulmonary Surfactant
Figure 75. Industry Chain Structure of Pulmonary Surfactant
Figure 76. Channels of Distribution
Figure 77. Global Pulmonary Surfactant Sales Market Forecast by Region (2026-2031)
Figure 78. Global Pulmonary Surfactant Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Pulmonary Surfactant Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Pulmonary Surfactant Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Pulmonary Surfactant Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Pulmonary Surfactant Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Pulmonary Surfactant
Figure 2. Pulmonary Surfactant Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pulmonary Surfactant Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Pulmonary Surfactant Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Pulmonary Surfactant Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Pulmonary Surfactant Sales Market Share by Country/Region (2024)
Figure 10. Pulmonary Surfactant Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Synthetic Pulmonary Surfactants
Figure 12. Product Picture of Animal Derived Surfactants
Figure 13. Global Pulmonary Surfactant Sales Market Share by Type in 2025
Figure 14. Global Pulmonary Surfactant Revenue Market Share by Type (2020-2025)
Figure 15. Pulmonary Surfactant Consumed in Hospital
Figure 16. Global Pulmonary Surfactant Market: Hospital (2020-2025) & (K Units)
Figure 17. Pulmonary Surfactant Consumed in laboratory
Figure 18. Global Pulmonary Surfactant Market: laboratory (2020-2025) & (K Units)
Figure 19. Pulmonary Surfactant Consumed in Others
Figure 20. Global Pulmonary Surfactant Market: Others (2020-2025) & (K Units)
Figure 21. Global Pulmonary Surfactant Sale Market Share by Application (2024)
Figure 22. Global Pulmonary Surfactant Revenue Market Share by Application in 2025
Figure 23. Pulmonary Surfactant Sales by Company in 2025 (K Units)
Figure 24. Global Pulmonary Surfactant Sales Market Share by Company in 2025
Figure 25. Pulmonary Surfactant Revenue by Company in 2025 ($ millions)
Figure 26. Global Pulmonary Surfactant Revenue Market Share by Company in 2025
Figure 27. Global Pulmonary Surfactant Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Pulmonary Surfactant Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Pulmonary Surfactant Sales 2020-2025 (K Units)
Figure 30. Americas Pulmonary Surfactant Revenue 2020-2025 ($ millions)
Figure 31. APAC Pulmonary Surfactant Sales 2020-2025 (K Units)
Figure 32. APAC Pulmonary Surfactant Revenue 2020-2025 ($ millions)
Figure 33. Europe Pulmonary Surfactant Sales 2020-2025 (K Units)
Figure 34. Europe Pulmonary Surfactant Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Pulmonary Surfactant Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Pulmonary Surfactant Revenue 2020-2025 ($ millions)
Figure 37. Americas Pulmonary Surfactant Sales Market Share by Country in 2025
Figure 38. Americas Pulmonary Surfactant Revenue Market Share by Country (2020-2025)
Figure 39. Americas Pulmonary Surfactant Sales Market Share by Type (2020-2025)
Figure 40. Americas Pulmonary Surfactant Sales Market Share by Application (2020-2025)
Figure 41. United States Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Pulmonary Surfactant Sales Market Share by Region in 2025
Figure 46. APAC Pulmonary Surfactant Revenue Market Share by Region (2020-2025)
Figure 47. APAC Pulmonary Surfactant Sales Market Share by Type (2020-2025)
Figure 48. APAC Pulmonary Surfactant Sales Market Share by Application (2020-2025)
Figure 49. China Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 53. India Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Pulmonary Surfactant Sales Market Share by Country in 2025
Figure 57. Europe Pulmonary Surfactant Revenue Market Share by Country (2020-2025)
Figure 58. Europe Pulmonary Surfactant Sales Market Share by Type (2020-2025)
Figure 59. Europe Pulmonary Surfactant Sales Market Share by Application (2020-2025)
Figure 60. Germany Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 61. France Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Pulmonary Surfactant Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Pulmonary Surfactant Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Pulmonary Surfactant Sales Market Share by Application (2020-2025)
Figure 68. Egypt Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Pulmonary Surfactant Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Pulmonary Surfactant in 2025
Figure 74. Manufacturing Process Analysis of Pulmonary Surfactant
Figure 75. Industry Chain Structure of Pulmonary Surfactant
Figure 76. Channels of Distribution
Figure 77. Global Pulmonary Surfactant Sales Market Forecast by Region (2026-2031)
Figure 78. Global Pulmonary Surfactant Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Pulmonary Surfactant Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Pulmonary Surfactant Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Pulmonary Surfactant Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Pulmonary Surfactant Revenue Market Share Forecast by Application (2026-2031)
